McHarg Selina, Clark Simon J, Day Anthony J, Bishop Paul N
Centre for Ophthalmology & Vision Sciences, Institute of Human Development, University of Manchester, Manchester, UK; Centre for Advanced Discovery & Experimental Therapeutics, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester, UK.
Mol Immunol. 2015 Sep;67(1):43-50. doi: 10.1016/j.molimm.2015.02.032. Epub 2015 Mar 21.
Age-related macular degeneration (AMD) is a leading cause of visual impairment. It is characterised by damage to a tissue complex composed of the retinal pigment epithelium, Bruch's membrane and choriocapillaris. In early AMD extracellular debris including drusen accumulates in Bruch's membrane and then in late AMD geographic atrophy and/or neovascularisation develop. Variants in genes encoding components of the alternative pathway of the complement cascade have a major influence on AMD risk, especially at the RCA locus on chromosome 1, which contains CFH and the CFHR genes. Immunohistochemical studies have demonstrated complement components in unaffected and AMD macular tissue. Whilst other factors, including oxidative stress, play important roles in AMD pathogenesis, evidence for the central role played by complement dysregulation is discussed in this review.
年龄相关性黄斑变性(AMD)是导致视力损害的主要原因。其特征是由视网膜色素上皮、布鲁赫膜和脉络膜毛细血管组成的组织复合体受损。在早期AMD中,包括玻璃膜疣在内的细胞外碎片在布鲁赫膜中积累,然后在晚期AMD中出现地图样萎缩和/或新生血管形成。编码补体级联替代途径成分的基因变异对AMD风险有重大影响,尤其是在1号染色体上的RCA位点,该位点包含CFH和CFHR基因。免疫组织化学研究已在未受影响和AMD黄斑组织中证实了补体成分。虽然包括氧化应激在内的其他因素在AMD发病机制中起重要作用,但本综述讨论了补体失调所起核心作用的证据。